| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $226.3M | — | -1.7% |
| R&D Expense | $6.5M | — | -53.2% |
| SG&A Expense | $26.2M | — | -11.2% |
| Operating Income | $31.7M | — | -9.9% |
| Interest Expense | $16.8M | — | +1.7% |
| Pre-tax Income | $21.0M | — | +10.8% |
| Income Tax | $7.9M | — | +14.5% |
| Net Income | $13.1M | — | +8.7% |
| EPS (Basic) | $0.10 | — | +11.1% |
| EPS (Diluted) | $0.10 | — | +11.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $103.5M | -17.3% | +47.3% |
| Accounts Receivable | $115.1M | +2.3% | -0.2% |
| Inventory | $101.8M | +3.0% | +8.5% |
| Current Assets | $430.5M | -0.3% | +21.5% |
| Total Assets | $1.28B | -1.7% | +3.5% |
| Current Liabilities | $259.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.2M | — | -122.3% |
| Capital Expenditures | $25.7M | — | +835.0% |
| Investing Cash Flow | -$11.9M | — | -390.6% |
| Financing Cash Flow | -$2.6M | — | -65.9% |
| Free Cash Flow | -$33.0M | — | -210.9% |
| +35.0% |
| Long-term Debt | $813.0M | -2.5% | -2.3% |
| Total Liabilities | $1.16B | -3.3% | +0.7% |
| Stockholders' Equity | $118.0M | +16.7% | +42.3% |